Dextera Surgical has enrolled first patient in the US under a registry to evaluate the use of the MicroCutter 5/80 surgical stapler in lung surgery.

The MicroCutter Assisted Thoracic Surgery Hemostasis (MATCH) registry is an open-label, multi-center registry, which will enroll about 120 patients undergoing lung resections that need surgical stapling.

It will evaluate the effectiveness of the MicroCutter 5/80 surgical stapler for hemostasis (stopping of blood flow) and the procedure allowing the aspects of the device in lobectomy or segmentectomy lung surgery procedures with the help of various minimally invasive techniques including video assisted thoracic surgery (VATS) and robotic assisted surgeries as well as in open surgery.

The MicroCutter 5/80 stapler is claimed to be the world’s first five-millimetre surgical stapler which can articulate to 80 degrees in each direction. It was manufactured in the US and has been cleared by the FDA in July, this year.

It has numerous applications for transection, resection in multiple open or minimally invasive urologic, thoracic and paediatric surgical procedures, along with applications in anastomoses in the small and the large intestine and the transection of the appendix.

Several medical centres in the US will be participating in the MATCH Registry, including Mayo Clinic in Rochester, Minnesota, University of Alabama at Birmingham, the University of Texas MD Anderson Cancer Center. 

Ten patients have already been enrolled internationally at the James Cook University Hospital (Middlesbrough, UK).

Dextera Surgical president and CEO Julian Nikolchev said: “We are proud to be working with these surgical pioneers at leading institutions to gather important clinical data on the MicroCutter 5/80 and its utility in thoracic surgery procedures.”

University of Texas MD Anderson Cancer Center, Houston professor David Rice said: “The MATCH Registry will provide important clinical data regarding the hemostasis performance of the MicroCutter 5/80 while capturing video evidence of the ability of the device to navigate in tight spaces to enable less-invasive methods for treating patients undergoing lung surgery.”